Top Companies in the Organ Preservation

The global organ preservation market is projected to reach USD 0.3 billion by 2030 from USD 0.2 billion in 2025, at a CAGR of 6.8% during the forecast period. The expansion of the organ preservation market is primarily fueled by several factors: a rise in multi-organ failure cases, an expanding elderly population, an increase in organ transplants and available donors, and heightened efforts to promote organ donation. However, significant hurdles to market growth include the high expenses associated with organ transplants and, in certain regions, religious objections.

The global organ preservation market is less fragmented and highly competitive. Some of the leading players profiled in the organ preservation market include Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), and Global Transplant Solutions (US) These companies are actively expanding their market footprint through strategies such as mergers & acquisitions, new product development, and geographic expansion.

1. In April 2024, Paragonix Technologies announced its participation in the American Transplant Congress (ATC) 2024 in Philadelphia, unveiling enhancements to its SherpaPak Cardiac Transport System, including real-time temperature analytics and integrated digital tracking. The company also revealed a strategic partnership with Bridge to Life Ltd. during the event to co-develop next-generation organ transport solutions. As part of this collaboration, both firms aim to merge Paragonix’s precision preservation technologies with Bridge to Life’s perfusion platforms to expand their collective offering across heart, lung, and liver preservation procedures.
2. In January 2024, XVIVO Perfusion AB partnered strategically with Getinge AB to integrate XVIVO’s lung perfusion systems with Getinge’s life-support and monitoring platforms. The announcement was made during Brussels's 2024 International Symposium on Intensive Care and Emergency Medicine (ISICEM). As part of this partnership, the companies plan to co-develop an AI-enabled monitoring solution for real-time perfusion assessment and jointly promote these technologies in transplant centers across Europe and North America.

To know about the assumptions considered for the study download the pdf brochure

Paragonix (US) is the leading market player in organ preservation. It operates mainly in the US and Europe. The company has been focused on developments such as new product launches, partnerships, agreements, and approvals since 2016. The company has developed devices for all thoracic & abdominal organ preservation. Paragonix also focuses on software services and tools for real-time organ tracking. Paragonix partnered with the Lung Transplant Foundation (US) to develop various technologies to improve donor lung preservation. In January 2021, the company partnered with Southwest Transplant Alliance (STA) to provide advanced organ preservation technologies. Such a development proves the company's strong market prevalence.

XVIVO Perfusion AB is a prominent market and public domain company. It is headquartered in Sweden and operates in Europe, Asia, the Middle East, and North & South America. It spends nearly 31% of its revenue on R&D, which is why the company is involved in developing improved products for organ perfusion. XVIVO’s lung perfusion solution is used mainly in Lung Preservation, making the solution a gold standard. In September 2020, XVIVO Perfusion entered an acquisition agreement with Organ Assist. This agreement further strengthened the company’s product range and expanded its addressable market.

Dr. Franz Kohler Chemie GmbH (Germany) is a leading market player in organ preservation solutions since 1959. It involves developing electrolyte solutions, organ-protective solutions, therapeutics, antidotes, X-ray contrast agents, and medical devices. It has captured the market for Custodial, an organ preservation solution. Custodial holds advantages over other solutions, like reduced viscosity and an improved graft survival rate, and is widely used to preserve all organs, unlike other solutions. These advantages of a Custodial solution for organ preservation prove that Dr. Franz Kohler Chemie GMBH holds a substantial market prevalence.

The top five companies in the organ preservation market are XVIVO Perfusion AB (Sweden), Paragonix Technologies (US), Dr. Franz Köhler Chemie GmbH (Germany), Bridge to Life Ltd. (US), and OrganOx Ltd. (UK). These companies have established themselves through innovative product portfolios, strategic collaborations, and strong geographic presence. XVIVO Perfusion AB leads in machine perfusion technologies and has consistently expanded its offerings through research investments and global partnerships. Paragonix Technologies continues strengthening its market presence by integrating digital platforms with its transport systems and entering collaborative agreements. Dr. Franz Köhler Chemie GmbH maintains a robust position by focusing on preservation solutions for multiple organs, backed by a strong distribution network. Bridge to Life and OrganOx have expanded their influence via clinical trials, technology advancements, and partnerships with transplant centers and academic institutions, securing their roles as key players in the evolving organ preservation ecosystem.

Related Reports:

Organ Preservation Market by Solution Type (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com